Home

Pipeline

 

We have currently two drug discovery programs:

Huntington's disease and a transcription factor inhibitor for cancer treatment.

 

Read more...

 

 

 

 

Conferences

 

APG will be an exhibitor at the BioEntrepreneur Summit on the 10./11. October in Martinsried near Munich.

 

We will be presenting and are available for discussions at BioEurope on November 6-8 at the CityCube in Berlin.

News

 

APG has received an EU grant by the PERMIDES initiative to establish an in silico drug discory platform.

 

Read more...

Our novel approach to inhibit mutated proteins in Huntington's disease is now supported by a European Union grant from EIT Health.

We are proud to announce that we received a European Union funded grant under the PERMIDES program. We are customizing in silico screening and modeling software for our new drug discovery platform for oncological targets.